LINCOLN PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Lincoln Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.28₹ -1.35
As on Jan 12, 2026, 4:01 PM IST
Lincoln Pharmaceuticals Price Performance
Today's LowToday's High
₹482.85₹489.70
₹486.00
52 Weeks' Low52 Weeks' High
₹466.00₹837.85
₹486.00
Open Price
₹484.35
Prev. Close
₹487.35
Volume
135
Over the last 5 years, the share price of Lincoln Pharmaceuticals has gained 15.47% CAGR. Over the past year, the corresponding return has been -39.68%.
Lincoln Pharmaceuticals’s current P/E of 12.17x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Lincoln Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lincoln Pharmaceuticals | 1.24 | 0.60 | -7.38 | -11.27 | -36.72 | 12.37 | 15.47 |
| Sun Pharmaceutical Industries | -1.46 | -3.50 | 3.95 | 3.11 | -0.67 | 19.69 | 22.81 |
| Divi's Laboratories | -2.29 | 2.29 | -0.95 | -4.29 | 13.26 | 22.83 | 11.17 |
| Torrent Pharmaceuticals | 0.29 | 4.43 | 12.17 | 15.88 | 21.90 | 36.14 | 22.58 |
| Cipla | -4.20 | -2.73 | -6.26 | -1.25 | 1.89 | 10.76 | 11.35 |
| Dr. Reddy's Laboratories | -3.24 | -5.09 | -3.70 | -2.85 | -8.91 | 12.32 | 2.33 |
| Lupin | 1.76 | 4.77 | 11.14 | 13.77 | 1.66 | 42.37 | 15.28 |
| Mankind Pharma | -0.87 | 3.71 | -8.99 | -17.68 | -14.21 | 15.99 | 9.31 |
| Zydus Lifesciences | -3.68 | -2.63 | -9.72 | -7.38 | -7.93 | 25.16 | 12.70 |
| Alkem Laboratories | 3.85 | 4.52 | 6.76 | 21.26 | 12.23 | 23.97 | 13.68 |
| Aurobindo Pharma | -4.89 | -1.19 | 3.05 | 2.87 | 0.83 | 37.57 | 3.96 |
| Abbott India | -0.06 | 1.86 | -5.16 | -17.37 | -0.47 | 8.98 | 12.89 |
| Glenmark Pharmaceuticals | -2.82 | 1.54 | 5.49 | -9.12 | 34.61 | 67.31 | 30.97 |
| Laurus Labs | -6.78 | 3.57 | 18.76 | 26.21 | 86.15 | 40.05 | 24.33 |
| Biocon | -3.69 | -5.04 | 6.17 | -2.20 | 1.66 | 12.87 | -4.67 |
| GlaxoSmithKline Pharmaceuticals | -3.37 | -6.85 | -12.81 | -24.74 | 14.76 | 22.42 | 8.90 |
| Ipca Laboratories | 5.36 | 7.39 | 17.02 | 6.23 | -2.01 | 21.13 | 7.94 |
| Anthem Biosciences | -3.86 | -11.65 | -21.33 | -15.47 | -15.47 | -5.45 | -3.30 |
| Ajanta Pharma | -3.97 | 3.60 | 13.08 | 3.22 | -1.79 | 32.73 | 17.78 |
| J B Chemicals & Pharmaceuticals | -0.20 | 4.57 | 12.73 | 14.28 | 5.42 | 25.12 | 29.19 |
Over the last one year, Lincoln Pharmaceuticals has declined 36.72% compared to peers like Sun Pharmaceutical Industries (-0.67%), Divi's Laboratories (13.26%), Torrent Pharmaceuticals (21.90%). From a 5 year perspective, Lincoln Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (22.81%) and Divi's Laboratories (11.17%).
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 485.19 | 484.64 |
| 10 | 483.69 | 484.45 |
| 20 | 482.71 | 486.02 |
| 50 | 501.69 | 498.07 |
| 100 | 521.32 | 516.01 |
| 200 | 542.03 | 545.34 |
Lincoln Pharmaceuticals Share Holding Pattern
In the latest quarter, Lincoln Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.01%, FII holding fell to 4.73%, and public shareholding moved up to 45.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lincoln Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 10, 2026, 10:17 PM IST | Lincoln Pharmace - Announcement under Regulation 30 (LODR)-Credit Rating |
| Jan 07, 2026, 12:19 AM IST | Lincoln Pharmace - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Nov 13, 2025, 6:03 AM IST | Lincoln Pharmace - UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 |
| Nov 13, 2025, 5:58 AM IST | Lincoln Pharmace - Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 |
| Nov 05, 2025, 8:34 PM IST | Lincoln Pharmace - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial |
About Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 623.23 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressLincoln House, Ahmedabad Gujarat 380060
- Contact
Management
- Mr. Kishor M ShahNon Executive Chairman
- Mr. Mahendra G PatelManaging Director
- Mr. Hashmukh I PatelWhole Time Director
- Mr. Munjal M PatelWhole Time Director
- Mr. Ashish R PatelWhole Time Director
- Mr. Rajnikant G PatelNon Executive Director
- Mr. Nareshkumar SutharIndependent Director
- Mr. Saurin J ParikhIndependent Director
- Ms. Seema MehtaIndependent Director
FAQs on Lincoln Pharmaceuticals Share Price
What is the share price of Lincoln Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lincoln Pharmaceuticals is ₹486.00 as on Jan 12, 2026.
What kind of stock is Lincoln Pharmaceuticals?
The Lincoln Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Lincoln Pharmaceuticals?
The market cap of Lincoln Pharmaceuticals is ₹973.44 Cr as on Jan 12, 2026.
What are today's High and Low prices of Lincoln Pharmaceuticals?
Today’s highest and lowest price of Lincoln Pharmaceuticals are ₹489.70 and ₹482.85.
What are the 52 Week High and 52 Week Low of Lincoln Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Lincoln Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Lincoln Pharmaceuticals is ₹837.85 and 52-week low of Lincoln Pharmaceuticals is ₹466.00 as on Jan 12, 2026.
How has the Lincoln Pharmaceuticals performed historically in terms of returns?
The Lincoln Pharmaceuticals has shown returns of -0.28% over the past day, 0.96% for the past month, -8.05% over 3 months, -39.68% over 1 year, 12.37% across 3 years, and 15.47% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lincoln Pharmaceuticals?
P/E ratio of and PB ratio of Lincoln Pharmaceuticals are 12.17 and 1.36 on Jan 12, 2026. While the company gives a dividend yield of 0.37 per annum.
✕
Market Pulse